Cargando…
Ceftobiprole: pharmacokinetics and PK/PD profile
Ceftobiprole shows many similar pharmacokinetic properties to other cephalosporins, except for not being orally bioactive, and that it is administered by IV infusion as the prodrug ceftobiprole medocaril, which is subsequently hydrolyzed in the blood into the active molecule. Distribution focus in e...
Autores principales: | Azanza Perea, José Ramón, Díaz de Rada, Belén Sádaba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755345/ https://www.ncbi.nlm.nih.gov/pubmed/31364336 |
Ejemplares similares
-
Possible clinical indications of ceftobiprole
por: Barberán, José
Publicado: (2019) -
Safety and tolerability of ceftobiprole
por: Grau, Santiago
Publicado: (2019) -
Ceftobiprole for the treatment of pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019) -
Mechanisms of action and antimicrobial activity of ceftobiprole
por: Morosini, María-Isabel, et al.
Publicado: (2019) -
Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting
por: Perea, José Ramón Azanza, et al.
Publicado: (2022)